Browse all practice questions for the CITI Good Clinical Practice (GCP) Practice Exam. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

CITI Good Clinical Practice (GCP) Practice Exam course image
Understanding Adverse Events: A Core Element of Good Clinical PracticeWhat is an adverse event (AE)?Understanding Participant Rights: The Freedom to Withdraw in Clinical TrialsWhat should subjects be informed about regarding their withdrawal from a study?Understanding the consequences of protocol violations in clinical trialsWhat could be a consequence of a protocol violation in a clinical trial?Understanding the Definition of an Audit According to ICH E6According to ICH E6, what is the definition of an "audit"?Understanding the Importance of CMC Information in IND ReferencesWhat type of information must not be duplicated when referencing another IND?Understanding the primary purpose of a Humanitarian Device Exemption in medical device regulationWhat is the primary purpose of a Humanitarian Device Exemption (HDE)?Understanding the Risk-Based Approach in Clinical TrialsWhat approach does the ICH E6(R2) integrated addendum require sponsors to use in managing trial quality?Understanding the Role of Sponsors in Clinical InvestigationsWhat is a primary responsibility of sponsors in a clinical investigation?Understanding the Role of the Clinical Trial Sponsor in Regulatory ComplianceWho is primarily responsible for regulatory compliance in a clinical trial?Understanding What Needs to Be Disclosed in Informed Consent FormsWhat must be disclosed to subjects in the informed consent form according to ICH E6 guidelines?What matters in drug accountability during clinical trials: tracking receipt, return, and destruction of investigational productsWhat is an essential aspect of drug accountability during clinical trials?Why Maintaining Data Integrity is Crucial in Clinical TrialsIn clinical trials, why should data integrity be maintained?Why the clinical trial master file matters: keeping transparency and regulatory compliance in GCPIn GCP, what is the primary reason for maintaining a clinical trial master file?
More practice questions

These questions are part of the practice quiz. Start practicing

  • What is the overall goal of monitoring, audits, and inspection activities?
  • What must an investigator agree to when signing Form FDA 1572?
  • Which condition would exempt a study from requiring an IND?
  • What does "accountability" in clinical trials refer to?
  • Which of the following is essential to the validity of clinical trial results?
  • Which of the following is NOT considered a serious adverse event?
  • What does 21 CFR 56 relate to?
  • What purpose do written Standard Operating Procedures (SOPs) serve?
  • Under which condition does the FDA permit verbal consent without a signature?
  • What is the role of a Clinical Research Associate (CRA)?
  • Which entity is responsible for reporting the investigator's financial interests to the FDA?
  • According to ICH E6, how should risks be managed throughout the trial process?
  • How does GCP address participant safety in clinical trials?
  • In the context of clinical trials, what does "protocol adherence" refer to?
  • What is the goal of obtaining informed consent from study participants?
  • What is the significance of inclusion and exclusion criteria in clinical studies?
  • What does a report of an unexpected adverse event indicate to the sponsor?
  • What is the importance of training for trial personnel in GCP?
  • What is the purpose of Form FDA 1572?
  • What information related to subjects’ biospecimens must be included in the consent form?
  • How should recruitment for clinical trial participants be conducted?
  • What critical information must be communicated to participants during the informed consent process?
  • What defines a Humanitarian Use Device (HUD)?
  • What defines an Adverse Event (AE) in clinical investigations?
  • How is an Adverse Drug Reaction (ADR) defined before market approval?
  • How is an "inspection" defined according to ICH E6?
  • What role does the Institutional Review Board (IRB) play in clinical trials?
  • What does "data integrity" refer to in clinical research?
  • What does the consent form need to state regarding the number of subjects in a study?
  • What is a key ethical consideration in clinical trials?
  • What must be verified about the regulations when obtaining informed consent?
  • What is an Unanticipated Adverse Device Effect?
  • What is a Letters of Cross-Reference used for in clinical trials?
  • What is a key consideration when obtaining consent from subjects for clinical trials?
  • What type of device presents a potential for serious risk to the health or safety of subjects?
  • What should an investigator do upon learning that a subject has been in a car crash resulting in injury?
  • What does the term "Device" refer to in the context of clinical research?
  • Why is it essential to document training for all trial personnel?
  • How is a placebo used in clinical trials?
  • Why is data integrity critical in clinical trials?
  • What must an investigator complete when conducting a study under an IDE?
  • Which scenario requires the submission of an SAE report?
  • What aspect is crucial when determining the causality of an adverse event?
  • What must the consent form include regarding access to medical records?
  • What does Form FDA 1571 represent?
  • What is included in the informed consent process?
  • Which document outlines broader confidentiality requirements related to medical records than those required by the FDA or HHS?
  • Which of the following best defines an Investigational New Drug (IND)?
  • How should the integrity of trial data be maintained?
  • What is the significance of clinical trial registration?
  • What role do statistical methods play in clinical trial design?
  • What does signing the Form FDA 1572 require from the investigator?
  • What information is typically included in a Clinical Study Report (CSR)?
  • What is the definition of a clinical trial?
  • Which activity would not typically be a focus during routine monitoring?
  • What is a protocol violation in clinical trials?
  • What should an investigator do if a new beneficial drug becomes available during a clinical study?
  • What must be documented according to Good Clinical Practice (GCP)?
  • What is a key consideration for maintaining informed consent during a clinical trial?
  • What is an Investigational New Drug Application (IND)?
  • What should be documented when a drug is dispensed to a subject?
  • Which of the following is NOT a responsibility of the investigator?
  • What is the primary purpose of Good Clinical Practice (GCP)?
  • Who is responsible for determining the causality of a serious adverse event in a clinical trial?
  • Which of the following happens after an investigational study is terminated?
  • What is a key outcome of disclosing conflicts of interest?
  • What constitutes a 'treatment group' in a clinical trial?
  • What must be discussed with subjects regarding risks in the consent process?
  • What is the purpose of providing a statement of conflicts of interest?
  • What does an Investigator's Brochure contain?
  • What does the term "Biological Product" refer to?
  • Where is information on the storage requirements for an investigational product typically found?
  • What must an investigator submit to the sponsor if they are involved in a new protocol?
  • What is the significance of a Data and Safety Monitoring Board (DSMB)?
  • In which scenario is an explanation required in the consent form for research involving more than minimal risk?
  • What is an Investigational Product?
  • How does trial monitoring relate to GCP compliance?
  • What constitutes exculpatory language in a consent form?
  • What must be done if a deviation from the protocol occurs?
  • Which of the following is NOT a benefit of effective monitoring in clinical trials?
  • When must investigators inform subjects about significant new findings during a study?
  • According to FDA regulations, what type of copy of the informed consent form can subjects receive?
  • At which stage are regulatory documents generated for a site?
  • What is the definition of Good Clinical Practice (GCP)?
  • Which factor may complicate the determination of an adverse event's causality?
  • Who is responsible for reporting Unanticipated Adverse Device Effects to the FDA?
  • What type of adverse event requires additional medical intervention to prevent lasting impairment?
  • What defines a non-compliance issue in clinical trials?
  • What type of language should be avoided in the consent form?
  • What is an investigator's responsibility according to GCP?
  • What must be included in the consent forms regarding the probability of assignment to trial arms?
  • What should an investigator do regarding informed consent?
  • What role does the informed consent process play in GCP?
  • What does a well-designed clinical trial aim to achieve?
  • In a clinical study, an investigator finds a subject with elevated WBC counts but no symptoms. What should be done?
  • How can trial sponsors ensure participant recruitment is ethical?
  • Which of the following is NOT a requirement for informed consent?
  • Who can the investigator delegate responsibilities for product accountability to?
  • What does "blinding" refer to in clinical trials?
  • Why is investigator training necessary in GCP?
  • How often should the consent process be reviewed in clinical trials?
  • What is the role of regulatory authorities in clinical trials?
  • How should clinical trial data be recorded according to GCP?
  • What is the primary function of an Institutional Review Board (IRB)?
  • What component is crucial for drug accountability during clinical trials?
  • Which document is critical for the sponsor-investigator relationship?
  • What is the purpose of a protocol in clinical trials?
  • Why should investigators report findings of adverse events promptly?
  • What does the term "informed consent document" refer to?
  • What does the term “subject safety” encompass in clinical trials?
  • Why is it important to maintain confidentiality of participant data?
  • What is the purpose of Form FDA 1572, Statement of Investigator?
  • What happens at the end of a study regarding investigational agents?
  • What financial information must investigators report under 21 CFR 54?
  • What immediate action should be taken for an adverse event that is life-threatening?
  • What does the term “informed consent” mean in clinical research?
  • How are evaluations of Unanticipated Adverse Device Effects transmitted to the FDA?
  • What is the role of the Case Report Form in clinical trials?
  • What is the primary purpose of conducting a clinical trial?
  • Why is it essential for informed consent forms to include participant withdrawal rights?
  • What is the purpose of randomization in clinical trials?
  • How should investigators manage protocol amendments?
  • During an FDA inspection, what will the inspectors primarily review?
  • What criteria classify an event as "unexpected" in the context of serious adverse events?
  • How often must the IRB review ongoing clinical trials?
  • What must researchers ensure before starting a clinical trial?
  • What type of costs should be outlined in the consent form for subjects?
  • What key principles are outlined in the Declaration of Helsinki?
  • What is the significance of blinding in clinical trials?
  • When must a sponsor submit an IND Safety Report to the FDA?
  • Why is it important for clinical trials to adhere to ethical guidelines?
  • In what setting do ethical review boards operate?
  • Which study visits review subjects' signed informed consent forms?
  • Which type of device is required to have an IDE before clinical trials can begin?
  • What is the purpose of a prestudy visit?
  • What must sponsors ensure regarding the investigators involved in their studies?
  • Why is compliance with regulatory requirements important in GCP?
  • What is the purpose of monitoring in clinical trials?
  • When should the sponsor-monitor conduct the most detailed review of the study protocol with the site's study staff?
  • What is the function of a clinical trial master file?
  • What is a primary reason for adhering to inclusion and exclusion criteria in trials?
  • What is essential for obtaining informed consent from participants?
  • What role does the sponsor play in a clinical trial?
  • What is OHRP primarily concerned with?
  • What is the importance of an independent monitor in a clinical trial?
  • Which statement best describes the role of the IRB in emergency situations involving informed consent?
  • What type of information should be included in a clinical trial protocol?
  • What is the role of the Investigator in a clinical trial under an IDE?
  • When must the consent for participation in clinical trials be obtained?
  • Why is accurate reporting of adverse events essential?
  • What is required at a prestudy site visit?
  • What organization holds the main oversight responsibility for ethical aspects of clinical trials?
  • Why is the Institutional Review Board (IRB) essential in clinical trials?
  • Why is the documentation of informed consent critical?
  • What must be submitted to the FDA before conducting a clinical trial for specific devices?
  • What is the key role of an investigator in a clinical study?
  • To whom must an investigator report all adverse events during a clinical trial?
  • What is the status of the ICH E6 guidelines in the United States?
  • What is a critical component of the informed consent process?
  • Who is responsible for the annual reporting of an IND to the FDA?
  • What is an investigator primarily responsible for protecting during a study?
  • Which aspect is crucial in obtaining informed consent from participants?
  • What kind of products does the term “Biologics” encompass?
  • How does GCP ensure trial transparency?
  • What is a key ethical consideration in clinical research?
  • What is meant by “risk assessment” in GCP?
  • At what visit should all unused investigational agents be returned to the sponsor?
  • Which organization developed the International Conference on Harmonisation (ICH) guidelines for GCP?
  • What is the role of conflicts of interest management plans in clinical trials?
  • What does GCP require regarding the reporting of adverse events?
  • Which monitoring visit would not include an inventory of investigational agents?
  • What is a serious adverse event (SAE)?
  • What is an essential requirement for proper participant recruitment in clinical trials?
  • Which of the following outcomes categorizes an event as a Serious Adverse Event (SAE)?
  • Which document is not essential for participating in a clinical trial?
  • What is the main responsibility of the investigator in relation to an investigational product?
  • What does the term "prospective study" imply in clinical research?
  • Which statement accurately describes an Investigational Drug?
  • Which type of device study is characterized by minimal risk to patients?
  • What is required for a 510(k) Premarket Notification submission?
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy